Single User License
INR 202133
Site License
INR 404265
Corporate User License
INR 606398

Service Tax Additional

select a format
Price

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Fibromyalgia-Current and Future Players

Fibromyalgia-Current and Future Players


  Request for Sample Report

Executive Summary

Fibromyalgia-Current and Future Players

Summary

GlobalData has released its pharma report, "Fibromyalgia-Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Fibromyalgia Market. The report identifies and analyses the key companies shaping and driving the global Fibromyalgia market. The report provides insight into the competitive Fibromyalgia landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.

Scope

Investigation of current and future market competition for Fibromyalgia

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Fibromyalgia sector through market impact analysis, future market scenario and company analysis

Reasons To Buy

Gain a high level view of the trends shaping and driving Fibromyalgia market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What's the next big thing in the global Fibromyalgia market landscape? Identify, understand and capitalize

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Catalyst 6

2.2 Related Reports 6

2.3 Upcoming Related Reports 7

3 Market Outlook 8

3.1 Global Markets 8

3.1.1 Forecast 8

3.1.2 Drivers and Barriers-Global Issues 12

4 Current and Future Players 13

4.1 Overview 13

4.2 Trends in Corporate Strategy 16

4.3 Company Profiles 17

4.3.1 Pfizer 17

4.3.2 Eli Lilly 20

4.3.3 Forest Laboratories (Actavis) 23

4.3.4 Daiichi Sankyo 26

4.3.5 Tonix Pharmaceuticals 29

4.3.6 Theravance Biopharma 32

5 Appendix 36

5.1 Bibliography 36

5.2 Abbreviations 46

5.3 Methodology 51

5.4 Forecasting Methodology 51

5.4.1 Diagnosed Fibromyalgia Patients 51

5.4.2 Percentage of Drug-Treated Patients 52

5.4.3 Drugs Included in Each Therapeutic Class 52

5.4.4 Launch and Patent Expiry Dates 52

5.4.5 General Pricing Assumptions 53

5.4.6 Individual Drug Assumptions 54

5.4.7 Generic Erosion 57

5.4.8 Pricing of Pipeline Agents 57

5.5 Primary Research-KOLs Interviewed for This Report 59

5.6 Primary Research-Prescriber Survey 60

5.7 About the Authors 61

5.7.1 Analyst 61

5.7.2 Therapy Area Director 61

5.7.3 Epidemiologist 62

5.7.4 Global Head of Healthcare 62

5.8 About GlobalData 63

5.9 Disclaimer 63

1.2 List of Figures

Figure 1: Global Sales for Fibromyalgia by Region, 2013-2023 11

Figure 2: Global Sales of Branded Products for Fibromyalgia by Company, 2013-2023 15

Figure 3: Company Portfolio Gap Analysis in Fibromyalgia, 2013-2023 16

Figure 4: Pfizer's SWOT Analysis in Fibromyalgia, 2013-2023 20

Figure 5: Eli Lilly SWOT Analysis in Fibromyalgia, 2013-2023 23

Figure 6: Forest Laboratories (Actavis) SWOT Analysis in Fibromyalgia, 2013-2023 26

Figure 7: Daiichi Sankyo SWOT Analysis in Fibromyalgia, 2013-2023 29

Figure 8: Tonix Pharmaceuticals SWOT Analysis in Fibromyalgia, 2013-2023 32

Figure 9: Theravance Biopharma SWOT Analysis in Fibromyalgia, 2013-2023 35

1.1 List of Tables

Table 1: Global Sales Forecasts (USD m) for Fibromyalgia, 2013-2023 10

Table 2: Global Fibromyalgia Market-Drivers and Barriers, 2013-2023 12

Table 3: Key Companies in the Fibromyalgia Market in the 7MM, 2014 14

Table 4: Pfizer's Fibromyalgia Portfolio Assessment, 2014 18

Table 5: Eli Lilly's Fibromyalgia Portfolio Assessment, 2014 21

Table 6: Forest Laboratories' (Actavis) Fibromyalgia Portfolio Assessment, 2014 24

Table 7: Daiichi Sankyo's Fibromyalgia Portfolio Assessment, 2014 27

Table 8: Tonix Pharmaceutical's Fibromyalgia Portfolio Assessment, 2014 30

Table 9: Theravance Biopharma's Fibromyalgia Portfolio Assessment, 2014 33

Table 10: Key Launch Dates for Fibromyalgia Drugs in the 7MM 52

Table 11: Key Patent Expiries for the Marketed Drugs Indicated for Fibromyalgia 53

Table 12: High-Prescribing Physicians (Non-KOLs) Surveyed, by Country 60

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pfizer

Eli Lilly

Forest Laboratories (Actavis)

Daiichi Sankyo

Tonix Pharmaceuticals

Theravance Biopharma


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com